Terence Herman
Medical Oncology · Harlingen, TXNPI 1124097498
Payments from drug & device makers
Across 100 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$291
- Seagen Inc.$173
- Bristol Myers Squibb$141
- Daiichi Sankyo Inc.$137
- Sobi, Inc$125
- Lilly USA, LLC$119
- plus $872 from 26 others
What the payments were for
- Food & beverage$1,81398%
- Education$442%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 15 | $291 |
| Seagen Inc. | 11 | $173 |
| Bristol Myers Squibb | 6 | $141 |
| Daiichi Sankyo Inc. | 7 | $137 |
| Sobi, Inc | 6 | $125 |
| Lilly USA, LLC | 7 | $119 |
| Sanofi | 4 | $91 |
| Eisai Inc. | 5 | $87 |
| Bayer | 3 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Gilead | 3 | $55 |
| Astellas Pharma US Inc | 3 | $51 |
| Genentech USA, Inc. | 2 | $50 |
| Jazz Pharmaceuticals Inc. | 2 | $44 |
| Johnson & Johnson | 2 | $38 |
| Novartis | 2 | $35 |
| EMD Serono, Inc. | 2 | $31 |
| Tolmar, Inc. | 2 | $31 |
| Brainlab, Inc. | 1 | $25 |
| GSK | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
| Pharmaessentia USA Corporation | 1 | $18 |
| AstraZeneca | 1 | $18 |
| Novocure Inc. | 1 | $18 |
| Array Biopharma Inc | 1 | $17 |
| GT Medical Technologies, Inc | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $17 |
| Immunogen, Inc. | 1 | $17 |
| Mevion_medical_systems_inc | 2 | $16 |
| Amgen | 1 | $14 |
| AVEO Pharmaceuticals, Inc. | 1 | $13 |
| Karyopharm Therapeutics Inc. | 1 | $13 |
How this compares
$1,857 in reported general payments places this provider in the 20th percentile of 495 medical oncology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exemestane | 12 | $4,411 |
| Amlodipine Besylate | 13 | $116 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Harlingen
- Hagop KantarjianHouston$100.5M
- Timothy YapHouston$56.7M
- Yasir ElaminHouston$41.3M
- David HongHouston$31.6M
- Guillermo Garcia-ManeroHouston$31.6M
- Jason WestinHouston$30.8M
- Sawsan RashdanDallas$29.9M
- Lucia MasarovaHouston$29.7M
- Jordi Rodon AhnertHouston$28.1M
- Sarina Piha PaulHouston$26M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.